吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jul 8 2019

Full Issue

Judge To Hear Arguments Over Johnson & Johnson's Motion To Dismiss Oklahoma Opioids Case

The drugmaker's lawyers and prosecutors for the state of Oklahoma will each have an hour Monday to address Johnson & Johnson's motion that the trial judge toss the case. "One would expect vigorous arguments, somewhat akin to a late July 4th fireworks display," court spokesman Bob Burke said. Other news on the opioid epidemic comes out of New Hampshire and North Carolina.

Drugmaker Johnson & Johnson has asked the judge presiding over the historic Oklahoma opioid trial to toss the case, saying the company has been made a "scapegoat" and blasting the state's effort as a "slew of illogical, legally defective theories far outside the bounds of Oklahoma precedent." Cleveland County District Judge Thad Balkman will give both parties an hour Monday morning to argue their case before deciding whether to throw it out or to allow it to proceed. (Drash, 7/7)

So far, Oklahoma Attorney General Mike Hunter has secured about $355 million from two groups of defendant drugmakers in the state's lawsuit against opioid manufacturers, and he's trying to make the case that even more money should come Oklahoma's way in the first such state case to go to trial. While Hunter presses the claim that Johnson & Johnson is to blame for Oklahoma's opioid epidemic, he's also facing criticism, some from his own Republican colleagues, about his team's deal making and go-it-alone style. (Murphy, 7/4)

Johnson & Johnson was the 鈥渒ingpin鈥 behind the opioid crisis in Oklahoma, providing the raw materials that fueled the addiction epidemic, state officials argued during the first half of a landmark trial that could have ramifications for hundreds of similar lawsuits across the country. ...Oklahoma officials say they will need to devote $17.8 billion over 30 years to address the fallout from the public health crisis, with the bulk of that money going to help addicts recover. They say Johnson & Johnson should be on the hook for at least part of that bill. (Demko, 7/2)

Federal rulings, legal activism and an explosion of inmates with opioid addictions are moving county jail administrators to do the previously unthinkable 鈥 providing anti-opioid medication behind the walls. A 2018 Pew Charitable Trusts study concluded less than 1% of the incarcerated got one of the three drugs known to help addicts kick opioids 鈥 Suboxone, Vivitrol and methadone 鈥 even though three out of four living in most prisons come there with a substance abuse problem. Instead, incarcerated addicts dealt with the physically and psychologically painful symptoms of withdrawal with sometimes tragic overdose outcomes. (Landrigan, 7/6)

State officials announced last month that more than 12,000 people with substance use disorder entered addiction treatment since North Carolina received $54 million in federal grant funding to address the opioid crisis. Opioid addiction is widespread in North Carolina, and an average of five people die per day from overdose. It affects people across the state from every race and socio-economic background. (Knopf, 7/8)

A Portsmouth doctor has been reprimanded and fined by the New Hampshire Board of Medicine after he cut back a chronic pain patient鈥檚 prescription opioid painkillers 鈥 and then dropped him as a patient altogether after the man threatened suicide. Joshua Greenspan, who is board certified in pain management and anesthesiology, signed a settlement agreement in May to resolve allegations of professional misconduct. Greenspan did not respond to a message left at his office at the American Pain Institute on Friday. (Wickham, 7/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, August 7
  • Thursday, August 6
  • Wednesday, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF